[{"AccountsPayableCurrent_0_Q3_USD":1754000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":90826000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":9645000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":247000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":91914000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":144000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":55000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-1000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":53331000.0,"OtherLiabilitiesCurrent_0_Q3_USD":49000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":5000.0,"OtherAssetsNoncurrent_0_Q3_USD":3583000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":398000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":12643000.0,"OperatingLeasePayments_3_Q3_USD":3760000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":10921000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3580000.0,"OperatingIncomeLoss_3_Q3_USD":-60774000.0,"OperatingIncomeLoss_1_Q3_USD":-30142000.0,"OperatingExpenses_3_Q3_USD":87681000.0,"OperatingExpenses_1_Q3_USD":30142000.0,"NetIncomeLoss_3_Q3_USD":-60639000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-2000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1169000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":5476000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":23288000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":49488000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":51232000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":67000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":378000.0,"StockholdersEquity_0_Q3_USD":251367000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.43,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":3.1,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q3_USD":8.8,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q3_shares":4915000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q3_USD":11048000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":8.88,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7592000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":13244000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":7.22,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":4.24,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1678000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":12.42,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":294000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":2900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":100000.0,"ShareBasedCompensation_3_Q3_USD":8686000.0,"RevenueFromRelatedParties_3_Q3_USD":26907000.0,"RevenueFromRelatedParties_1_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-211640000.0,"RestrictedCashNoncurrent_0_Q3_USD":1300000.0,"RestrictedCash_0_Q3_USD":1270000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":65895000.0,"NetIncomeLoss_1_Q3_USD":-30093000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-55293000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-38830000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":91995000.0,"CommonStockValue_0_Q3_USD":51000.0,"CommonStockSharesOutstanding_0_Q3_shares":51240000.0,"CommonStockSharesIssued_0_Q3_shares":51240000.0,"CommonStockSharesAuthorized_0_Q3_shares":160000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9746000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-2128000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":146635000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":145365000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":77000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":29438000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":74235000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":23000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":4000.0,"AssetsCurrent_0_Q3_USD":229245000.0,"Assets_0_Q3_USD":280385000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":8055000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":8381000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8686000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2926000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2926000.0,"AdditionalPaidInCapital_0_Q3_USD":462975000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-19000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":6419000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":12714000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-603000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-30088000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":51232000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-60641000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":18097000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":280385000.0,"Liabilities_0_Q3_USD":29018000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-175000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-360000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-1931000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":640000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-290000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":9000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":6000.0,"IncomeTaxesPaid_3_Q3_USD":8000.0,"IncomeLossAttributableToParent_3_Q3_USD":-60630000.0,"IncomeLossAttributableToParent_1_Q3_USD":-30087000.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q3_USD":0.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q3_USD":53100000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":21786000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6854000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":14200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5897000.0,"EarningsPerShareDiluted_3_Q3_USD":-1.23,"EarningsPerShareDiluted_1_Q3_USD":-0.59,"EarningsPerShareBasic_3_Q3_USD":-1.23,"EarningsPerShareBasic_1_Q3_USD":-0.59,"DueFromRelatedPartiesCurrent_0_Q3_USD":0.0,"Depreciation_3_Q3_USD":2184000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q3_USD":0.0,"ContractWithCustomerLiability_0_Q3_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":49488000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]